Skip to main content
Clinical Trials/NCT03744364
NCT03744364CompletedPhase 4

Low-dose Vaginal Misoprostol Versus Vaginal Dinoprostone Insert for Induction of Labor Beyond 41st Week: a Randomized Trial

Hospital Miguel Servet0 sites198 target enrollmentStarted: June 1, 2014Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 4
Status
Completed
Sponsor
Enrollment
198
Primary Endpoint
Successful vaginal delivery within 24 hours

Study Overview

Brief Summary

Purpose:

To compare the efficacy and safety of low-dose protocol of vaginal misoprostol and vaginal dinoprostone insert for induction of labor in women with post-term pregnancies.

Methods:

The investigators designed a prospective, randomized, open-labeled, blinded for the end-point evaluators trial including women of at least 41 weeks of gestational age with uncomplicated singleton pregnancies and Bishop score lower than 6. Participants were randomized into dinoprostone or misoprostol groups in a 1:1 ratio. Baseline maternal data and perinatal outcomes were recorded for statistical analysis. Successful vaginal delivery within 24 hours was the primary outcome variable.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 50 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Singleton uncomplicated pregnancy
  • Nulliparity
  • Live fetus
  • 286 days of gestational age or above
  • Abscence of contraindication for vaginal delivery
  • Bishop score lower than 6

Exclusion Criteria

  • Multiple pregnancy
  • Multiparity
  • Stillbirth
  • Oligohydramnios
  • Suspected fetal distress
  • Severe asthma
  • Intolerance/allergy to prostaglandins
  • Contraindication for vaginal birth

Arms & Interventions

Misoprostol

Active Comparator

Group of women allocated to misoprostol induction.

Intervention: Misoprostol 25 mcg (Drug)

Dinoprostone

Active Comparator

Group of women allocated to dinoprostone induction.

Intervention: Dinoprostone 10mg (Drug)

Outcomes

Primary Outcomes

Successful vaginal delivery within 24 hours

Time Frame: 24 hours since induction was started

Percentage of women that achieve a vaginal delivery within 24 hours since induction process started

Secondary Outcomes

  • Need for a second induction(Assessed 24 hours since induction of labor was started)
  • Vaginal delivery rate(Since labor induction had started until delivery had ocurred within 72 hours)
  • Successful cervical ripening within 24 hours(24 hours since induction was started)
  • Interval time from induction to delivery(Hours passed between induction of labor until delivery within 72 hours)

Investigators

Sponsor
Hospital Miguel Servet
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Jose Manuel Campillos Maza

Head of Unit of Maternal-Fetal Medicine

Hospital Miguel Servet

Similar Trials